4.2 Abstract in Atti di convegno

4.2 Abstract in Atti di convegno: [3017] Home page tipologia

Sfoglia

Prodotti della tipologia (ordinati per Data di deposito in Decrescente ordine): 861 a 880 di 3.017

PROFILING THE MUTATIONAL LANDSCAPE OF ACUTE MYELOID LEUKEMIA AT RELAPSE AFTER CHEMOTHERAPY AND ALLOGENEIC HEMATOPOIETIC STEM CELL TRANSPLANTATION

2017-01-01 Sala, E; Biavasco, F; Bucci, G; Toffalori, C; Zanotti, L; Biancolini, D; Antonini, E; Carrabba, Mg; Gentner, B; Tresoldi, C; Bernardi, M; Lazarevic, D; Tonon, G; Ciceri, F; Vago, L

Clinical and Translational Results of a Phase II Randomized Trial o Maintenance Sunitinib (MS) or Observation (O) n Metastatic Pancreatic Adenocarcinoma

2012-01-01 Reni, M; Cereda, S; Novarino, A; Milella, M; Passardi, A; Belli, C; Di Lucca, G; Mambrini, A; Ferrari, L; Danova, M; Bergamo, F; Franceschi, E; Giovannetti, E; Rovati, B; Gallà, V; Villa, E

C-Myc- Dependent Stabilization of Hif-1alpha in MM: Therapeutic Implications

2008-01-01 Podar, K; Zhang, J; Tonon, G; Grabher, C; Lababidi, S; Raab, Ms; Vallet, S; Zhou, Ym; Cartron, Ma; Sattler, M; Chauhan, D; Anderson, Kc

Correlating treatment planning data with late rectum bleeding in the treatment of poster cancer

2000-01-01 Fiorino, C; Bianchi, C; Piazzola, A; Cozzarini, C; Vavassori, V; Cattaneo, G. M.; Magli, A; Mordacchini, C; Reni, M

JunB/AP-1 controls MM cell proliferation, survival and drug resistance in the bone marrow microenvironment

2014-01-01 Fan, Fj; Vallet, S; Sattler, M; Tonon, G; Bashari, Mh; Bakiri, L; Goldschmidt, H; Wagner, Ef; Jaeger, D; Podar, K

PEFG salvage therapy inpatients with gemcitabine-resistant advanced pancreatic cancer (PC)

2006-01-01 Cereda, S; Mazza, E; Passoni, P; Nicoletti, R; Balzano, G; Zerbi, A; Staudacher, C; di Carlo, V; Reni, M

Identification of new human liver cancer genes by a novel lentiviral vector-based insertional mutagenesis approach in three mouse models of hepatocarcinogenesis

2011-01-01 Ranzani, M; Cesana, D; Bartholomae, C; Sanvito, F; Pala, M; Benedicenti, F; Sergi, Ls; Bulfone, A; Doglioni, C; von Kalle, C; Schmidt, M; Tonon, G; Naldini, L; Montini, E

Randomized phase II trial on primary chemotherapy with high-dose methotrexate (HD-MTX) alone or associated with high-dose cytarabine (HD-araC) for patients with primary CNS lymphoma (IELSG #20 Trial): Tolerability, activity, and survival analyses

2009-01-01 Ferreri, Aj; Reni, M; Martelli, M; Pangalis, G; Frezzato, M; Cabras, G; Fabbri, A; Corazzelli, G; Zucca, E; Cavalli, F

Final results of a multicentre phase II trial of high-dose methotrexate (HD-MTX), cytarabine, thiotepa, and idarubicin (MATILDE regimen) followed by whole-brain irradiation (WBRT) for primary CNS lymphomas (PCNSL)

2005-01-01 Ferreri, Aj; Dell'Oro, S; Foppoli, M; Brandes, Aa; Montanari, M; Balzarotti, M; Spina, M; Ilariucci, F; Zaja, F; Reni, M

CS1 Promotes Multiple Myeloma Cell Adhesion, Clonogenic Growth, and Tumorigenicity via c-Maf Mediation

2009-01-01 Tai, Yt; Soydan, E; Fulciniti, M; Song, W; Kim, K; Hong, F; Li, Xf; Burger, P; Rumizen, M; Nahar, S; Podar, K; Chauhan, D; Hideshima, T; Munshi, Nc; Tonon, G; Carrasco, R; Anderson, Kc

PEFG salvage therapy in patients with gemcitabine-resistant advanced pancreatic cancer (PC)

2006-01-01 Cereda, S; Mazza, E; Vitali, G; Passoni, P; Balzano, G; Zerbi, A; Staudacher, C; Di Carlo, V; Reni, M

A "static" karyotype in epithelial cancer cell lines despite ongoing chromsomal instability

2000-01-01 Roschke, Av; Stover, K; Tonon, G; Schaffer, Aa; Kirsch, Ir

Chemotherapy for recurrent ependymomas in adults: Gruppo Italiano Cooperativo Neurooncologia (GICNO) study

2004-01-01 Brandes, Aa; Cavallo, G; Reni, M; Tosoni, A; Nicolardi, L; Scelzi, F; Morabito, A; Scopece, L; Franceschi, E; Ermani, M

Angiogenesis Associated with Alterations of the Bone Marrow Microenvironment Predicts Multiple Myeloma Progression to Symptomatic Disease in Mice and Humans

2014-01-01 Calcinotto, A; Ponzoni, M; Ria, R; Grioni, M; Cattaneo, E; Villa, I; Bertilaccio, Mts; Chesi, M; Rubinacci, A; Tonon, G; Bergsagel, Pl; Vacca, A; Bellone, M

Significant Association Between VEGF-A and ABCB1 Polymorphisms and Survival in Metastatic Pancreatic Adenocarcinoma (MPA) patients (Pts) treated with Maintenance Sunitinib (MS)

2012-01-01 Reni, M; Giovannetti, E; Cereda, S; Belli, C; Passardi, A; Di Lucca, G; Ferrari, L; Bergamo, F; Novarino, A; Verheul, Hm

Lentiviral vector-based insertional mutagenesis identifies new clinically relevant cancer genes involved in the pathogenesis of hepatocellular carcinoma

2011-01-01 Ranzani, M; Cesana, D; Bartholomae, C; Sanvito, F; Pala, M; Benedicenti, F; Gallina, P; Sergi, L; Merella, S; Bulfone, A; Doglioni, C; von Kalle, C; Kim, Yj; Schmidt, M; Tonon, G; Naldini, L; Montini, E

Association between DNA repair polymorphisms and survival in cancer cancer patients treated with combination chemotherapy

2010-01-01 Pacetti, P; Giovanetti, E; Reni, M; Mambrini, A; Ghidini, M; Gleon, L; Funel, N; Cereda, S; Peters, G; Cantore, M.

Loss of the Histone Demethylase UTX Contributes to Multiple Myeloma and Sensitizes Cells to EZH2 Inhibitors

2014-01-01 Ezponda, T; Popovic, R; Zheng, Yp; Nabet, B; Will, C; Small, Ec; Occhionorelli, M; Tonon, G; Keats, Jj; Kelleher, Nl; Licht, Jd

Adjuvant PEFG (cisplatin, epirubicin, 5-fluorouracil, gemcitabine) or gemcitabine in pancreatic cancer: a randomized phase II trial

2009-01-01 Reni, M; Cereda, S; Aprile, G; Tronconi, Mc; Milandri, C; Passoni, P; Rognone, A; Balzano, G; Di Carlo, V; Villa, E

Up-regulation of c-Jun contributes to induction of apoptosis by Adaphostin in human multiple myeloma cells

2005-01-01 Podar, K; Tonon, G; Raab, Ms; Sattler, M; Abtahi, D; Tai, Yt; Legouill, S; Ishitsuka, K; Yasui, H; Depinho, Ra; Hideshima, T; Chauhan, D; Anderson, Kc

Titolo	Data di pubblicazione	Autore(i)
PROFILING THE MUTATIONAL LANDSCAPE OF ACUTE MYELOID LEUKEMIA AT RELAPSE AFTER CHEMOTHERAPY AND ALLOGENEIC HEMATOPOIETIC STEM CELL TRANSPLANTATION	1-gen-2017	Sala, E; Biavasco, F; Bucci, G; Toffalori, C; Zanotti, L; Biancolini, D; Antonini, E; Carrabba, Mg; Gentner, B; Tresoldi, C; Bernardi, M; Lazarevic, D; Tonon, G; Ciceri, F; Vago, L
Clinical and Translational Results of a Phase II Randomized Trial o Maintenance Sunitinib (MS) or Observation (O) n Metastatic Pancreatic Adenocarcinoma	1-gen-2012	Reni, M; Cereda, S; Novarino, A; Milella, M; Passardi, A; Belli, C; Di Lucca, G; Mambrini, A; Ferrari, L; Danova, M; Bergamo, F; Franceschi, E; Giovannetti, E; Rovati, B; Gallà, V; Villa, E
C-Myc- Dependent Stabilization of Hif-1alpha in MM: Therapeutic Implications	1-gen-2008	Podar, K; Zhang, J; Tonon, G; Grabher, C; Lababidi, S; Raab, Ms; Vallet, S; Zhou, Ym; Cartron, Ma; Sattler, M; Chauhan, D; Anderson, Kc
Correlating treatment planning data with late rectum bleeding in the treatment of poster cancer	1-gen-2000	Fiorino, C; Bianchi, C; Piazzola, A; Cozzarini, C; Vavassori, V; Cattaneo, G. M.; Magli, A; Mordacchini, C; Reni, M
JunB/AP-1 controls MM cell proliferation, survival and drug resistance in the bone marrow microenvironment	1-gen-2014	Fan, Fj; Vallet, S; Sattler, M; Tonon, G; Bashari, Mh; Bakiri, L; Goldschmidt, H; Wagner, Ef; Jaeger, D; Podar, K
PEFG salvage therapy inpatients with gemcitabine-resistant advanced pancreatic cancer (PC)	1-gen-2006	Cereda, S; Mazza, E; Passoni, P; Nicoletti, R; Balzano, G; Zerbi, A; Staudacher, C; di Carlo, V; Reni, M
Identification of new human liver cancer genes by a novel lentiviral vector-based insertional mutagenesis approach in three mouse models of hepatocarcinogenesis	1-gen-2011	Ranzani, M; Cesana, D; Bartholomae, C; Sanvito, F; Pala, M; Benedicenti, F; Sergi, Ls; Bulfone, A; Doglioni, C; von Kalle, C; Schmidt, M; Tonon, G; Naldini, L; Montini, E
Randomized phase II trial on primary chemotherapy with high-dose methotrexate (HD-MTX) alone or associated with high-dose cytarabine (HD-araC) for patients with primary CNS lymphoma (IELSG #20 Trial): Tolerability, activity, and survival analyses	1-gen-2009	Ferreri, Aj; Reni, M; Martelli, M; Pangalis, G; Frezzato, M; Cabras, G; Fabbri, A; Corazzelli, G; Zucca, E; Cavalli, F
Final results of a multicentre phase II trial of high-dose methotrexate (HD-MTX), cytarabine, thiotepa, and idarubicin (MATILDE regimen) followed by whole-brain irradiation (WBRT) for primary CNS lymphomas (PCNSL)	1-gen-2005	Ferreri, Aj; Dell'Oro, S; Foppoli, M; Brandes, Aa; Montanari, M; Balzarotti, M; Spina, M; Ilariucci, F; Zaja, F; Reni, M
CS1 Promotes Multiple Myeloma Cell Adhesion, Clonogenic Growth, and Tumorigenicity via c-Maf Mediation	1-gen-2009	Tai, Yt; Soydan, E; Fulciniti, M; Song, W; Kim, K; Hong, F; Li, Xf; Burger, P; Rumizen, M; Nahar, S; Podar, K; Chauhan, D; Hideshima, T; Munshi, Nc; Tonon, G; Carrasco, R; Anderson, Kc
PEFG salvage therapy in patients with gemcitabine-resistant advanced pancreatic cancer (PC)	1-gen-2006	Cereda, S; Mazza, E; Vitali, G; Passoni, P; Balzano, G; Zerbi, A; Staudacher, C; Di Carlo, V; Reni, M
A "static" karyotype in epithelial cancer cell lines despite ongoing chromsomal instability	1-gen-2000	Roschke, Av; Stover, K; Tonon, G; Schaffer, Aa; Kirsch, Ir
Chemotherapy for recurrent ependymomas in adults: Gruppo Italiano Cooperativo Neurooncologia (GICNO) study	1-gen-2004	Brandes, Aa; Cavallo, G; Reni, M; Tosoni, A; Nicolardi, L; Scelzi, F; Morabito, A; Scopece, L; Franceschi, E; Ermani, M
Angiogenesis Associated with Alterations of the Bone Marrow Microenvironment Predicts Multiple Myeloma Progression to Symptomatic Disease in Mice and Humans	1-gen-2014	Calcinotto, A; Ponzoni, M; Ria, R; Grioni, M; Cattaneo, E; Villa, I; Bertilaccio, Mts; Chesi, M; Rubinacci, A; Tonon, G; Bergsagel, Pl; Vacca, A; Bellone, M
Significant Association Between VEGF-A and ABCB1 Polymorphisms and Survival in Metastatic Pancreatic Adenocarcinoma (MPA) patients (Pts) treated with Maintenance Sunitinib (MS)	1-gen-2012	Reni, M; Giovannetti, E; Cereda, S; Belli, C; Passardi, A; Di Lucca, G; Ferrari, L; Bergamo, F; Novarino, A; Verheul, Hm
Lentiviral vector-based insertional mutagenesis identifies new clinically relevant cancer genes involved in the pathogenesis of hepatocellular carcinoma	1-gen-2011	Ranzani, M; Cesana, D; Bartholomae, C; Sanvito, F; Pala, M; Benedicenti, F; Gallina, P; Sergi, L; Merella, S; Bulfone, A; Doglioni, C; von Kalle, C; Kim, Yj; Schmidt, M; Tonon, G; Naldini, L; Montini, E
Association between DNA repair polymorphisms and survival in cancer cancer patients treated with combination chemotherapy	1-gen-2010	Pacetti, P; Giovanetti, E; Reni, M; Mambrini, A; Ghidini, M; Gleon, L; Funel, N; Cereda, S; Peters, G; Cantore, M.
Loss of the Histone Demethylase UTX Contributes to Multiple Myeloma and Sensitizes Cells to EZH2 Inhibitors	1-gen-2014	Ezponda, T; Popovic, R; Zheng, Yp; Nabet, B; Will, C; Small, Ec; Occhionorelli, M; Tonon, G; Keats, Jj; Kelleher, Nl; Licht, Jd
Adjuvant PEFG (cisplatin, epirubicin, 5-fluorouracil, gemcitabine) or gemcitabine in pancreatic cancer: a randomized phase II trial	1-gen-2009	Reni, M; Cereda, S; Aprile, G; Tronconi, Mc; Milandri, C; Passoni, P; Rognone, A; Balzano, G; Di Carlo, V; Villa, E
Up-regulation of c-Jun contributes to induction of apoptosis by Adaphostin in human multiple myeloma cells	1-gen-2005	Podar, K; Tonon, G; Raab, Ms; Sattler, M; Abtahi, D; Tai, Yt; Legouill, S; Ishitsuka, K; Yasui, H; Depinho, Ra; Hideshima, T; Chauhan, D; Anderson, Kc

Prodotti della tipologia (ordinati per Data di deposito in Decrescente ordine): 861 a 880 di 3.017

Legenda icone

file ad accesso aperto
file disponibili sulla rete interna
file disponibili agli utenti autorizzati
file disponibili solo agli amministratori
file sotto embargo
nessun file disponibile

Scopri

Accesso al fulltext

no fulltext2961
reserved34
open22